This contract expires in 434 days (Sep 29, 2027).
THUNDERCAT TECHNOLOGY, LLC - MED HYPERCONVERGED NUTANIX SW FOR VISN 20 - SINGLE YEAR
Key Details
Description
MED HYPERCONVERGED NUTANIX SW FOR VISN 20 - SINGLE YEAR
Context & Analysis
Department of Veterans Affairs obligated $1,330,177.92 to THUNDERCAT TECHNOLOGY, LLC for med hyperconverged nutanix sw for visn 20 - single year. Performance is located in OR. The contract is scheduled through Sep 29, 2027 — approximately 14 months remaining. This award is one of several similar procurements from Department of Veterans Affairs — related awards are listed below.
Contractor Information
Similar Awards
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE THE DEPARTMENT OF VETERANS AFFAIRS WITH AN ENTERPRISE AGREEMENT FOR BRAND NAME MICROSOFT SOFTWARE PRODUCTS AND SERVICES. THIS ENTERPRISE AGREEMENT WILL PROVIDE 1) SUPPORT SERVICES 2) OPERATIONAL SUPPORT AND 3) ADDITIONAL LICENSES OF MICROSOFT PRODUCTS, CURRENT AND PLANNED, TO SUPPORT THE VA ENTERPRISE. SUBJECT PROCUREMENT WAS COMPETED AMONG MICROSOFT'S EIGHT AUTHORIZED FEDERAL GOVERNMENT LICENSE SOLUTION PROVIDERS. IGF::OT::IGF
DELL FEDERAL SYSTEMS L.P
$1.7B
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE THE DEPARTMENT OF VETERANS AFFAIRS WITH AN ENTERPRISE AGREEMENT FOR BRAND NAME MICROSOFT SOFTWARE PRODUCTS AND SERVICES. THIS ENTERPRISE AGREEMENT WILL PROVIDE 1) SUPPORT SERVICES 2) OPERATIONAL SUPPORT AND 3) ADDITIONAL LICENSES OF MICROSOFT PRODUCTS, CURRENT AND PLANNED, TO SUPPORT THE VA ENTERPRISE. SUBJECT PROCUREMENT WAS COMPETED AMONG MICROSOFT'S EIGHT AUTHORIZED FEDERAL GOVERNMENT LICENSE SOLUTION PROVIDERS. IGF::OT::IGF
DELL FEDERAL SYSTEMS L.P
$1.7B
IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES, TO INCLUDE HOSTING, FOR THE EHRM APPLICATIONS, APPLICATION SERVICES, AND ALL SUPPORTING EHRM DATA.
ORACLE HEALTH GOVERNMENT SERVICES, INC.
$1.5B
EHRM WAVES K, L, M (VISN 23) AND N, O (VISN 15) DEPLOYMENTS
ORACLE HEALTH GOVERNMENT SERVICES, INC.
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
Stay Updated
Get notified about new opportunities matching your interests.